REQUEST A DEMO
Total
USD $0.00
Search more companies

Sunty Development Co., Ltd. (Taiwan, China)

Main Activities: Nonresidential Building Construction
Secondary Activities: Machinery, Equipment, and Supplies Merchant Wholesalers
Full name: Sunty Development Co., Ltd. Profile Updated: August 04, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Chinese Download a sample report

In March 1993, Sunty Property Development Co., Ltd. was established. In May, it signed with Japanese Biochemical Industry Co., Ltd. to be an exclusive agency of Yan Jie product in the Republic of China, and with the Swiss Vifor International to be an exclusive agency of chalybeate product in Taiwan. In December 2000, it got the exclusive right for Aimiluo product of Elvis Asia Limited (IVAXASIA LTD) and Likuining product of Yeung Sum (JANSSEN-CILAG Taiwan) in Republic of China. In May 2002, it signed with the Masterlink Securities Corp. OTC to get counseling for listing. In October, it got the exclusive rights for paclitaxel injection (Genetaxyl), PPV and sugar tablet provided by JANSSEN-CILAG Taiwan. In April 2003, it issued public offering. In September, it signed with Jacob Biotech Co., Ltd. to be an exclusive agency of GSP injection in Taiwan. In October 2003, it was allowed to trade as Emerging Stock at GreTai Securities Market. In October 2003, it got the distribution rights for Dimicr-onMR from Singapore Business Servicer Co., Ltd. Taiwan Branch. In November, the company signed with Genovate Biotechnology Co., Ltd. to co-develop LNC drugs. In the same month, it became the general agency of Ya Jie Products for Japanese Biochemical Industry Co., Ltd.

Headquarters
12F, No.289, Sec.4, Zhongxiao E. Rd., Taipei, Taiwan
Taipei City; Taipei City;

Contact Details: Purchase the Sunty Development Co., Ltd. report to view the information.

Website: http://www.sunty.com.tw

Basic Information
Total Employees:
Purchase the Sunty Development Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Sunty Development Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Sunty Development Co., Ltd. report to view the information.
Ratings:
Purchase the Sunty Development Co., Ltd. report to view the information.
Incorporation Date:
March 17, 1993
Key Executives
Purchase this report to view the information.
Chairman of the Board of Directors
Purchase this report to view the information.
President
Purchase this report to view the information.
Spokesperson
Ownership Details
Purchase this report to view the information.
11.56%
Purchase this report to view the information.
1.43%
Purchase this report to view the information.
0.01%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Sheng Yang International Properties Co., L
100%
Sheng Yang Land Co., Ltd.
100%
Hsin Tong Yang Construction
74.78%
Company Performance
Financial values in the chart are available after Sunty Development Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
733.44%
Total operating revenue
733.44%
Operating profit (EBIT)
N/A
EBITDA
11717.08%
Net Profit (Loss) for the Period
N/A
Total assets
14.63%
Total equity
5.44%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
10.78%
Quick Ratio
0.01%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?